Morning After Tablet
Product Images NDC 69953-515

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Morning After (NDC 69953-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rapha Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Morning After (Ndc Submission Artwork)

This is a drug fact sheet for emergency contraceptive pills containing levonorgestrel as an active ingredient. This contraceptive is designed to reduce the chances of pregnancy after unprotected sex or if birth control failed. The effectiveness of the contraceptive increases with earlier use. However, the product does not protect against HIV/AIDS or STDs. The product also contains warnings and side effects. It is not for regular birth control. The pill is available over-the-counter and is manufactured by Rapha Pharmaceuticals, Inc. The company's contact information is provided as well.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.